Department of Neurosurgery, 285211Centro Hospitalar Universitário São João, Porto, Portugal.
26705Faculty of Medicine of the University of Porto, Porto, Portugal.
Interv Neuroradiol. 2022 Dec;28(6):675-681. doi: 10.1177/15910199211057738. Epub 2021 Nov 17.
Microsurgical clipping and endovascular coiling are viable treatment options for posterior communicating artery (PComA) aneurysms, but there are still major limitations to evidence-based decisions regarding standard-of-care treatment. In this study, we aimed at assessing potential selection biases that may influence our ability to extract conclusions about the comparative effectiveness or efficacy of the aneurysm treatment.
To study the patient/aneurysm characteristics as possible biases in the option for endovascular or neurosurgical treatment of PComA aneurysms.
A single-center, retrospective cohort study was performed, including all patients with treated PComA aneurysms with neurosurgical clipping or endovascular coiling between January 2010 and January 2021. Clinical and morphological data were collected from electronic records, and statistical analysis was performed.
A total of 64 patients was eligible for inclusion; 24 (37.5%) patients were proposed for neurosurgical treatment, while 40 (62.5%) for endovascular treatment; 10 patients (25%) crossed over to the clipping group whereas none crossed over to the coiling side. Actual treatment analysis showed significantly higher diameters of mother vessel (t-test, p = 0.034) and aneurysm neck (Mann-Whitney, p = 0.029) in the clipping group and higher aspect and dome-to-neck ratios in the endovascular group (Mann-Whitney, p = 0.008). A significantly higher vasospasm frequency was found in the clipping group but only in the intention-to-treat analysis (Chi-square, p = 0.032).
Significant morphological differences between effective endovascular and surgical groups and differences in intention-to-treat analysis may limit the validity of a direct comparison between treatment options and suggest the presence of a possible selection bias.
显微夹闭术和血管内介入治疗是治疗后交通动脉(PComA)动脉瘤的可行方法,但在基于证据的决策中,仍然存在关于标准治疗的主要局限性。在这项研究中,我们旨在评估可能的选择偏差,这些偏差可能会影响我们提取关于动脉瘤治疗的比较有效性或疗效的结论的能力。
研究患者/动脉瘤特征可能是选择血管内或神经外科治疗 PComA 动脉瘤的偏倚。
进行了一项单中心回顾性队列研究,纳入了 2010 年 1 月至 2021 年 1 月期间接受神经外科夹闭或血管内介入治疗的所有 PComA 动脉瘤患者。从电子病历中收集临床和形态学数据,并进行统计分析。
共有 64 名患者符合纳入标准;24 名(37.5%)患者被提议接受神经外科治疗,而 40 名(62.5%)患者接受血管内治疗;10 名(25%)患者从夹闭组转为夹闭组,而无人从介入组转为夹闭组。实际治疗分析显示,夹闭组母血管(t 检验,p = 0.034)和动脉瘤颈(Mann-Whitney,p = 0.029)直径明显较大,介入组形态和瘤颈比明显较高(Mann-Whitney,p = 0.008)。夹闭组的血管痉挛频率明显较高,但仅在意向治疗分析中(卡方检验,p = 0.032)。
有效血管内和手术组之间存在明显的形态学差异,以及意向治疗分析中的差异,可能限制了治疗选择之间的直接比较的有效性,并提示存在可能的选择偏倚。